Co-founder & CEO
Profile summary: Palantir Technologies • Forward Deployed Software Engineer, Enterprise Tech Lead
Level Zero Health
Level Zero Health offers a skin‑adhesive wearable patch that continuously measures cortisol, progesterone, estrogen, and testosterone in interstitial fluid using DNA‑aptamer sensors, delivering hormone data with 98 % accuracy comparable to blood tests. The device streams real‑time results to a cloud platform, enabling fertility clinics, IVF programs, and endocrinology practices to remotely monitor patients and adjust hormone therapies promptly.
- Digital Health
- Hardware
- Healthcare Technology
- Internet of Things
Updated 2 days ago
Funding
Raised to date
$6.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
+2$6.9M · Pre-Seed
Announced Feb 2025 · from article date
Disclosed cumulative: $6.9M
RoundDateAmountValuationInvestors
Founders
Product
Problem
Hormone levels are currently tracked through periodic blood draws, which are invasive, inconvenient, and provide only isolated snapshots of hormone concentrations. This limited data can miss rapid fluctuations, delaying diagnosis and treatment adjustments for conditions such as infertility, menopause, testosterone deficiency, and stress‑related disorders.
Solution
Level Zero Health has created a wearable patch that continuously measures hormone concentrations in interstitial fluid using DNA‑based sensing technology. The device captures real‑time hormone dynamics for cortisol, progesterone, estrogen, and testosterone, delivering data comparable to blood tests with 98 % accuracy across the clinical range. By transmitting measurements wirelessly, clinicians can remotely monitor patients and adjust therapies promptly. The patch is minimally invasive, adheres to the upper arm, and operates similarly to continuous glucose monitors, enabling users to go about daily activities while generating a granular hormonal profile.
Target Audience
Primary customers are fertility clinics, IVF programs, and endocrinology practices that require frequent hormone monitoring, as well as patients undergoing hormone‑related therapies such as testosterone replacement, menopause management, and stress‑related treatments.
Features
- DNA‑aptamer sensors that bind specific hormones and generate electrical signals in interstitial fluid
- Wearable, skin‑adhesive patch designed for continuous use on the arm
- Real‑time data streaming to a cloud platform for remote clinician access
- Validated accuracy of 98 % across the full human clinical hormone range in simulated samples
- Ability to monitor cortisol, progesterone, estrogen, and testosterone simultaneously
- Nanotechnology‑enhanced sensor architecture for low‑power operation and long wear time
- Integrated mobile app for users to view instantaneous hormone trends alongside other health metrics